Author
University of HelsinkiORCID 0000-0002-3987-1693Unclaimed ORCID profile · follow to get notified of new preprints
Mutual co-authors in cluster
5 papers
Recent·Most cited
Elham Gholizadeh, Ehsan Zangene, Uladzislau Vadadokhau…·Mohieddin Jafari
This paper introduces CoPISA, a proteomics workflow that identifies combination-specific protein targets in AML, revealing conjunctional targeting mechanisms beyond classical drug synergy.
Fadimana Kaya, Findlay Bewicke‐Copley, Juho Jalmari Miettinen…·Ana Rio‐Machín
This study identifies DEK::NUP214 as an XPO1-dependent transcriptional activator of leukemia genes, showing selective response to XPO1 inhibitors in t(6;9) AML cases.
Alina Malyutina, Philipp Sergeev, Julia Huber…·Caroline Akemi Heckman
This study identifies molecular mechanisms of carfilzomib resistance in multiple myeloma using multi-omics data from cell lines and patient samples, revealing potential drug combinations to overcome resistance.
Caroline Högel-Starck, Veera A. Timonen, Gantugs Atarsaikhan…·Esa Pitkänen
The paper develops Blood Cell Painting (BCP) to profile immune cell morphology in healthy donors, identifying genetic and clinical associations with immune cell features.
Pedro Casado, Ana Rio‐Machín, Juho Jalmari Miettinen…·Pedro R. Cutillas
The paper identifies two distinct subgroups of KMT2A-rearranged AML using phosphoproteomics and shows different drug response profiles.